Anaplastic lymphoma kinase (ALK) rearrangement, is a kind of driver mutation, accounts for 3%-5% of non-small celllung cancer (NSCLC). NSCLC patients harboring ALK fusion genes have distinct clinical features and good responseto ALK inhibitors. Metast...
Anaplastic lymphoma kinase (ALK) rearrangement, is a kind of driver mutation, accounts for 3%-5% of non-small celllung cancer (NSCLC). NSCLC patients harboring ALK fusion genes have distinct clinical features and good responseto ALK inhibitors. Metastasis from lung cancer to the ovary has rarely been known. We report a case of a 54-year-oldwoman with bilateral ovarian metastases from ALK rearranged NSCLC. She underwent bilateral salpingo-oophorectomyfor ovary masses, which were progressed after cytotoxic chemotherapy although primary lung mass was decreased. Histopathological examination of the ovary tumor showed characteristic adenocarcinoma patterns of the lung and ALKrearrangement.